Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis

Seminars in Nephrology

Volumn 30, Issue 2, 2010, Pages 164-176

  Ramos, Paula S ^a   Brown, Elisabeth E ^b   Kimberly, Robert P ^c   Langefeld, Carl D ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c The University of Alabama at Birmingham   (United States)

Author keywords

Genetics; Lupus nephritis; SLE; Systemic lupus erythematosus

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; HLA DQ ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; METHYL CPG BINDING PROTEIN 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OX40 LIGAND; STAT4 PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CAUCASIAN; EPIGENETICS; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS;

EID: 77950493632     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2010.01.007     Document Type: Article

References (108)

1. Helmick C.G., Felson D.T., Lawrence R.C., Gabriel S., Hirsch R., Kwoh C.K., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008, 58:15-25.
2. Cervera R., Albarca-Costalago M., Abramovicz D., Allegri F., Annunziata P., Aydintug A.O., et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev 2006, 5:180-186.
3. Block S.R. A brief history of twins. Lupus 2006, 15:61-64.
4. Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy-Burman P., et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35:311-318.
5. Alarcon-Segovia D., Alarcon-Riquelme M.E., Cardiel M.H., Caeiro F., Massardo L., Villa A.R., et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005, 52:1138-1147.
6. Hochberg M.C. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol 1987, 14:867-869.
7. Lawrence J.S., Martins C.L., Drake G.L. A family survey of lupus erythematosus. 1. Heritability. J Rheumatol 1987, 14:913-921.
8. Freedman B.I., Wilson C.H., Spray B.J., Tuttle A.B., Olorenshaw I.M., Kammer G.M. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997, 29:729-732.
9. Quintero-Del-Rio A.I., Kelly J.A., Kilpatrick J., James J.A., Harley J.B. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun 2002, 3(Suppl 1):S57-S62.
10. Ptacek T., Li X., Kelley J.M., Edberg J.C. Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res 2008, 123:142-147.
11. Pan Y., Sawalha A.H. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res 2009, 153:4-10.
12. Grumet F.C., Coukell A., Bodmer J.G., Bodmer W.F., McDevitt H.O. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med 1971, 285:193-196.
13. Waters H., Konrad P., Walford R.L. The distribution of HL-A histocompatibility factors and genes in patients with systemic lupus erythematosus. Tissue Antigens 1971, 1:68-73.
14. Tsao B.P., Wu H. The genetics of human lupus. Dubois' lupus erythematosus 2007, 54-81. Lippincott Williams & Wilkins, Philadelphia. 7th ed. D.J. Wallace, B.H. Hahn (Eds.).
15. Fernando M.M., Stevens C.R., Sabeti P.C., Walsh E.C., McWhinnie A.J., Shah A., et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007, 3:e192.
16. Graham R.R., Ortmann W., Rodine P., Espe K., Langefeld C., Lange E., et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 2007, 15:823-830.
17. Freedman B.I., Spray B.J., Heise E.R., Espeland M.A., Canzanello V.J. A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern Organ Procurement Foundation. Am J Kidney Dis 1993, 21:378-382.
18. Harley J.B., Sestak A.L., Willis L.G., Fu S.M., Hansen J.A., Reichlin M. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum 1989, 32:826-836.
19. Marchini M., Antonioli R., Lleo A., Barili M., Caronni M., Origgi L., et al. HLA class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol 2003, 64:462-468.
20. Ramos P.S., Langefeld C.D., Bera L.A., Gaffney P.M., Noble J.A., Moser K.L. Variation in the ATP-binding cassette transporter 2 gene is a separate risk factor for systemic lupus erythematosus within the MHC. Genes Immun 2009, 10:350-355.
21. Barcellos L.F., May S.L., Ramsay P.P., Quach H.L., Lane J.A., Nititham J., et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 2009, 5:e1000696.
22. Rioux J.D., Goyette P., Vyse T.J., Hammarstrom L., Fernando M.M., Green T., et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A 2009, 106:18680-18685.
23. Agnello V., De Bracco M.M., Kunkel H.G. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol 1972, 108:837-840.
24. Hauptmann G., Grosshans E., Heid E. Lupus erythematosus syndrome and complete deficiency of the fourth component of complement. Boll Ist Sieroter Milan 1974, 53(Suppl):228.
25. Nishino H., Shibuya K., Nishida Y., Mushimoto M. Lupus erythematosus-like syndrome with selective complete deficiency of C1q. Ann Intern Med 1981, 95:322-324.
26. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000, 76:227-324.
27. Walport M.J. Complement and systemic lupus erythematosus. Arthritis Res 2002, 4(Suppl 3):S279-S293.
28. Yang Y., Chung E.K., Wu Y.L., Savelli S.L., Nagaraja H.N., Zhou B., et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 2007, 80:1037-1054.
29. Brown E.E., Edberg J.C., Kimberly R.P. Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity 2007, 40:567-581.
30. Wu J., Edberg J.C., Redecha P.B., Bansal V., Guyre P.M., Coleman K., et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997, 100:1059-1070.
31. Salmon J.E., Millard S., Schachter L.A., Arnett F.C., Ginzler E.M., Gourley M.F., et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996, 97:1348-1354.
32. Kyogoku C., Dijstelbloem H.M., Tsuchiya N., Hatta Y., Kato H., Yamaguchi A., et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 2002, 46:1242-1254.
33. Lee Y.H., Ji J.D., Song G.G. Fcgamma receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Lupus 2009, 18:727-734.
34. Karassa F.B., Trikalinos T.A., Ioannidis J.P. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 2002, 46:1563-1571.
35. Karassa F.B., Trikalinos T.A., Ioannidis J.P. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int 2003, 63:1475-1482.
36. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002, 32:666-669.
37. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11:141-151.
38. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001, 291:319-322.
39. Ferreiros-Vidal I., Gomez-Reino J.J., Barros F., Carracedo A., Carreira P., Gonzalez-Escribano F., et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 2004, 50:2590-2597.
40. Lin S.C., Yen J.H., Tsai J.J., Tsai W.C., Ou T.T., Liu H.W., et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 2004, 50:770-775.
41. Sanghera D.K., Manzi S., Bontempo F., Nestlerode C., Kamboh M.I. Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies. Hum Genet 2004, 115:393-398.
42. Thorburn C.M., Prokunina-Olsson L., Sterba K.A., Lum R.F., Seldin M.F., Alarcon-Riquelme M.E., et al. Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 2007, 8:279-287.
43. Johansson M., Arlestig L., Moller B., Rantapaa-Dahlqvist S. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum 2005, 52:1665-1669.
44. Nielsen C., Laustrup H., Voss A., Junker P., Husby S., Lillevang S.T. A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients. Lupus 2004, 13:510-516.
45. Prokunina L., Gunnarsson I., Sturfelt G., Truedsson L., Seligman V.A., Olson J.L., et al. The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 2004, 50:327-328.
46. Lee Y.H., Woo J.H., Choi S.J., Ji J.D., Song G.G. Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus 2009, 18:9-15.
47. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337-338.
48. Kyogoku C., Langefeld C.D., Ortmann W.A., Lee A., Selby S., Carlton V.E., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004, 75:504-507.
49. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G., Nath S.K., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology (Oxford) 2007, 46:49-56.
50. Wu H., Cantor R.M., Graham D.S., Lingren C.M., Farwell L., Jager P.L., et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005, 52:2396-2402.
51. Gregersen P.K., Lee H.S., Batliwalla F., Begovich A.B. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006, 18:214-223.
52. Ronnblom L., Alm G.V., Eloranta M.L. Type I interferon and lupus. Curr Opin Rheumatol 2009, 21:471-477.
53. Sigurdsson S., Nordmark G., Goring H.H., Lindroos K., Wiman A.C., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005, 76:528-537.
54. Kyogoku C., Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 2007, 8:445-455.
55. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Bauer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006, 38:550-555.
56. Graham R.R., Kyogoku C., Sigurdsson S., Vlasova I.A., Davies L.R., Baechler E.C., et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 2007, 104:6758-6763.
57. Suarez-Gestal M., Calaza M., Endreffy E., Pullmann R., Ordi-Ros J., Domenico S.G., et al. Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 2009, 11:R69.
58. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41:1228-1233.
59. Amos C.I., Chen W.V., Lee A., Li W., Kern M., Lundsten R., et al. High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun 2006, 7:277-286.
60. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
61. Taylor K.E., Remmers E.F., Lee A.T., Ortmann W.A., Plenge R.M., Tian C., et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008, 4:e1000084.
62. Abelson A.K., Delgado-Vega A.M., Kozyrev S.V., Sanchez E., Velazquez-Cruz R., Eriksson N., et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 2009, 68:1746-1753.
63. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
64. Jacob C.O., Zang S., Li L., Ciobanu V., Quismorio F., Mizutani A., et al. Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J Immunol 2003, 171:1564-1571.
65. Kariuki S.N., Kirou K.A., MacDermott E.J., Barillas-Arias L., Crow M.K., Niewold T.B. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 2009, 182:34-38.
66. Jacob C.O., Reiff A., Armstrong D.L., Myones B.L., Silverman E., Klein-Gitelman M., et al. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum 2007, 56:4164-4173.
67. Jacob C.O., Zhu J., Armstrong D.L., Yan M., Han J., Zhou X.J., et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 2009, 106:6256-6261.
68. Martin M.U., Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 2002, 1592:265-280.
69. Sawalha A.H., Webb R., Han S., Kelly J.A., Kaufman K.M., Kimberly R.P., et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One 2008, 3:e1727.
70. Webb R., Wren J.D., Jeffries M., Kelly J.A., Kaufman K.M., Tang Y., et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum 2009, 60:1076-1084.
71. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
72. Urdinguio R.G., Lopez-Serra L., Lopez-Nieva P., Alaminos M., Diaz-Uriarte R., Fernandez A.F., et al. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One 2008, 3:e3669.
73. Cunninghame Graham D.S., Graham R.R., Manku H., Wong A.K., Whittaker J.C., Gaffney P.M., et al. Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 2008, 40:83-89.
74. Delgado-Vega A.M., Abelson A.K., Sanchez E., Witte T., D'Alfonso S., Galeazzi M., et al. Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus. Genes Immun 2009, 10:248-253.
75. Edberg J.C., Wu J., Langefeld C.D., Brown E.E., Marion M.C., McGwin G., et al. Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 2008, 17:1147-1155.
76. Jonsen A., Gunnarsson I., Gullstrand B., Svenungsson E., Bengtsson A.A., Nived O., et al. Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology (Oxford) 2007, 46:1417-1421.
77. Russell A.I., Cunninghame Graham D.S., Shepherd C., Roberton C.A., Whittaker J., Meeks J., et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004, 13:137-147.
78. Lee-Kirsch M.A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y.A., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007, 39:1065-1067.
79. Lehtinen D.A., Harvey S., Mulcahy M.J., Hollis T., Perrino F.W. The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease. J Biol Chem 2008, 283:31649-31656.
80. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
81. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40:204-210.
82. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008, 358:900-909.
83. Nath S.K., Han S., Kim-Howard X., Kelly J.A., Viswanathan P., Gilkeson G.S., et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 2008, 40:152-154.
84. Han S., Kim-Howard X., Deshmukh H., Kamatani Y., Viswanathan P., Guthridge J.M., et al. Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). Hum Mol Genet 2009, 18:1171-1180.
85. Buyon J.P., Shadick N., Berkman R., Hopkins P., Dalton J., Weissmann G., et al. Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus. Clin Immunol Immunopathol 1988, 46:141-149.
86. Graham R.R., Cotsapas C., Davies L., Hackett R., Lessard C.J., Leon J.M., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008, 40:1059-1061.
87. Tretter T., Ross A.E., Dordai D.I., Desiderio S. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk. J Exp Med 2003, 198:1863-1873.
88. Kozyrev S.V., Abelson A.K., Wojcik J., Zaghlool A., Linga Reddy M.V., Sanchez E., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008, 40:211-216.
89. Han J.W., Zheng H.F., Cui Y., Sun L.D., Ye D.Q., Hu Z., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009, 41:1234-1237.
90. Graham R.R., Hom G., Ortmann W., Behrens T.W. Review of recent genome-wide association scans in lupus. J Intern Med 2009, 265:680-688.
91. Freeman J.L., Perry G.H., Feuk L., Redon R., McCarroll S.A., Altshuler D.M., et al. Copy number variation: new insights in genome diversity. Genome Res 2006, 16:949-961.
92. McCarroll S.A., Kuruvilla F.G., Korn J.M., Cawley S., Nemesh J., Wysoker A., et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008, 40:1166-1174.
93. Aitman T.J., Dong R., Vyse T.J., Norsworthy P.J., Johnson M.D., Smith J., et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006, 439:851-855.
94. Fanciulli M., Norsworthy P.J., Petretto E., Dong R., Harper L., Kamesh L., et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007, 39:721-723.
95. Willcocks L.C., Lyons P.A., Clatworthy M.R., Robinson J.I., Yang W., Newland S.A., et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008, 205:1573-1582.
96. Ackerman L.S. Sex hormones and the genesis of autoimmunity. Arch Dermatol 2006, 142:371-376.
97. Costenbader K.H., Kim D.J., Peerzada J., Lockman S., Nobles-Knight D., Petri M., et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004, 50:849-857.
98. Cooper G.S., Gilbert K.M., Greidinger E.L., James J.A., Pfau J.C., Reinlib L., et al. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Environ Health Perspect 2008, 116:695-702.
99. Richardson B., Scheinbart L., Strahler J., Gross L., Hanash S., Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990, 33:1665-1673.
100. Corvetta A., Della B.R., Luchetti M.M., Pomponio G. 5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases. J Chromatogr 1991, 566:481-491.
101. Valley C.M., Willard H.F. Genomic and epigenomic approaches to the study of X chromosome inactivation. Curr Opin Genet Dev 2006, 16:240-245.
102. Niller H.H., Wolf H., Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 2008, 41:298-328.
103. Perl A., Nagy G., Koncz A., Gergely P., Fernandez D., Doherty E., et al. Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity 2008, 41:287-297.
104. Zhao S., Long H., Lu Q. Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin Rev Allergy Immunol 2009, Epub.
105. Dai Y., Huang Y.S., Tang M., Lv T.Y., Hu C.X., Tan Y.H., et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16:939-946.
106. Dai Y., Sui W., Lan H., Yan Q., Huang H., Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009, 29:749-754.
107. Tang Y., Luo X., Cui H., Ni X., Yuan M., Guo Y., et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009, 60:1065-1075.
108. Musone S.L., Taylor K.E., Lu T.T., Nititham J., Ferreira R.C., Ortmann W., et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 2008, 40:1062-1064.